Guardant Health
GH
#1787
Rank
HK$86.93 B
Marketcap
HK$662.73
Share price
-3.96%
Change (1 day)
88.76%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -HK$3.26 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$0.98 Billion. , an increase over its 2024 earnings that were of -HK$3.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -HK$3.28 Billion-4.03%
2024 -HK$3.41 Billion-9.12%
2023 -HK$3.76 Billion-26.73%
2022 -HK$5.12 Billion69.96%
2021 -HK$3.02 Billion56.35%
2020 -HK$1.93 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-HK$4.84 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$2.1 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA